Kevin Balthaser
Chief Financial Officer at Aclaris Therapeutics · 12 reported transactions in 1 company · latest report Mar 1, 2026
Their trades
Shares withheld for tax | Mar 1, 2026 | |||
Exercised options | Mar 1, 2026 | |||
Shares withheld for tax | Feb 3, 2026 | |||
Exercised options | Feb 3, 2026 | |||
Shares withheld for tax | Feb 1, 2026 | |||
Exercised options | Feb 1, 2026 | |||
Shares withheld for tax | Jan 2, 2026 | |||
Exercised options | Jan 2, 2026 | |||
Shares withheld for tax | Jan 1, 2026 | |||
Exercised options | Jan 1, 2026 |